Companies›Healthcare›Healthcare›Healthcare Services
NSE:VIJAYA

VIJAYA DIAGNOSTIC CEN LTD

Healthcare › Healthcare Services·NIFTY 500NIFTY MIDSMALLCAP 400NIFTY MIDSMALLCAP400 50:50NIFTY SMALLCAP 250+5
₹1,444.00
at close · 27 Oct 2026
▲ 46.00 (+3.29%)
ThemesArtificial Intelligence· growing

Latest filings

  1. Quarterly compliance certificate for demat and remat of securities · Compliance
  2. Trading Window Closure from Oct 1 ahead of Q2 results · Compliance
  3. All 7 resolutions passed at 24th AGM; final dividend of Rs 2 per share declared · Board & Shareholder Meetings
All filings ↓
Ask Nexa about VIJAYA DIAGNOSTIC CEN LTD

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Operates an integrated diagnostic services network under a hub-and-spoke model, selling pathology and radiology tests to retail and corporate customers across 6 states. The network has grown from 81 to 162 centers over five years, supported by a workforce of over 3,500 employees. Pathology and radiology contribute roughly equally to revenue, with a wellness segment growing around 30% year-on-year layered on top. Q4 FY26 revenue per patient was INR 1,808 and revenue per test was INR 488, with retail wellness realisations at INR 2,500 versus INR 2,000 for corporate customers. Hyderabad is the largest and most mature cluster, growing around 20% year-on-year, while Bangalore (with a Bannerghatta flagship featuring PET CT, high-end MRI and cardiac CT), Pune (under the PH Diagnostics brand), and Kolkata are the next priority geographies; new hubs in these markets have broken even within 9-12 months. The company owns and operates all centres directly (no franchise model) and plans 4-5 hubs and 10-12 spokes in FY27, plus an automated lab in Panjagutta, Hyderabad, with advanced genomic testing being introduced as a long-term play. The largest cost lines are other operating expenses (30.9% of revenue) and employee costs (16.1%), while materials — reagents and consumables — are only 11.6% of revenue, reflecting the asset-heavy, knowledge-labour nature of the business.

Operating scale
Diagnostic centres
162 centres across 6 statesFY26
Workforce
Over 3,500 employeesFY26
Revenue per patient
INR 1,808Q4 FY26
Revenue per test
INR 488Q4 FY26
FY27 network expansion plan
4-5 hubs and 10-12 spokesFY27
FY27 capex guidance
INR 140-150 croresFY27
Who pays it
Retail walk-in patients and corporate clients for pathology, radiology and preventive wellness packages
Biggest cost
Other operating expenses (rent, consumables, outsourced services) at 30.9% of revenue and employee costs at 16.1%
Kind of business
Asset-heavy, hub-and-spoke integrated diagnostic services network with high operating margins
Where it sits
Integrated B2C diagnostics operator expanding from its Hyderabad base into Bangalore, Pune and Kolkata, with no franchise model and no North India expansion planned for 3-5 years
Market Cap
₹14,858 Cr
P / E (TTM)
79.2×
EV / EBITDA
38.6×
Div Yield
0.14%
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
19.8%▲
ROCE (5y median)
ROE 18.1% (5y median) · margin 43.9%
Leverage
0.00·
Debt / Equity · low
Net cash ₹40 Cr
Revenue FY22→FY26
1.8×▲
Margin −2.7 pts
₹462 Cr → ₹814 Cr
Cash conversion
1.58×▲
Operating cash ÷ profit · 5 yrs
₹1,001 Cr on ₹632 Cr
Moves on a normal day
1.08%·
Median daily move
Last 268 sessions · the yardstick for filing-day moves
Where it sits among 29 Healthcare Service Provider peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#22/25
P/B#24/24
ROCE#6/29
ROE#4/24
Debt / Equity#1/23
EBITDA margin#3/24
Revenue growth#10/25
Profit growth#7/25

Scorecard

Measured from the filed financials, judged against its Healthcare Service Provider peers · as of FY26 — not investment advice

Strengths
Returns on capital 19.8% (5-year median)
#6 of 29 in Healthcare Service Provider on the latest reported figures · down from 25.3% in FY22
No borrowings on the balance sheet
lower than 77% of its 23 Healthcare Service Provider peers
Over 5 years it reported ₹632 Cr of profit and ₹1,001 Cr of operating cash — 1.58×
Profit is converting into cash
Negative working-capital cycle — the business is funded by its suppliers
Concerns
Nothing flagged in the filed numbers.

Charts

How has the market priced it — with filings on the timeline?

VIJAYA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from VIJAYA DIAGNOSTIC CEN LTD's filed financials and exchange disclosures

What does VIJAYA DIAGNOSTIC CEN LTD do?

VIJAYA DIAGNOSTIC CEN LTD is a Healthcare Services company listed on NSE and BSE, trading under the symbol VIJAYA.

Is VIJAYA DIAGNOSTIC CEN LTD profitable?

Yes. Over the trailing twelve months VIJAYA DIAGNOSTIC CEN LTD reported a net profit of ₹187 Cr on revenue of ₹857 Cr.

Does VIJAYA DIAGNOSTIC CEN LTD pay a dividend?

Yes. The dividend yield is 0.14% at the current price. It paid out 12% of its profit as dividend in FY26.

Is VIJAYA DIAGNOSTIC CEN LTD debt-free?

Yes. It reported no borrowings on its 31 Mar 2026 balance sheet, and ₹40 Cr of cash.

Is VIJAYA DIAGNOSTIC CEN LTD expensive compared with its peers?

On trailing P/E, VIJAYA DIAGNOSTIC CEN LTD ranks 22 of 25 in Healthcare Service Provider — cheaper than 13% of them, against an industry median of 23.6×. This is a position, not a valuation judgement.

How much does the VIJAYA DIAGNOSTIC CEN LTD share price move in a day?

On a typical session VIJAYA DIAGNOSTIC CEN LTD moves 1.08% — that is the median absolute close-to-close move across its last 268 trading days. MarketPing measures each filing's price reaction against it.

Where can I track VIJAYA DIAGNOSTIC CEN LTD's announcements?

Every NSE and BSE filing by VIJAYA DIAGNOSTIC CEN LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.